Developing an inclusion and safety monitoring assay for a cell therapy clinical trial

A cell and gene therapy biopharma company needed a partner for clinical trial support. The immediate need was a quick turnaround time for the development and validation of a biomarker assay using next-generation sequencing (NGS). In this case study from Azenta, explore how the biopharma company was able to develop a comprehensive, fit-for-purpose sample sourcing, assay, and logistics solution that can extend further to the storage of samples.